Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nature ; 575(7784): 652-657, 2019 11.
Article in English | MEDLINE | ID: mdl-31748747

ABSTRACT

Mosaic loss of chromosome Y (LOY) in circulating white blood cells is the most common form of clonal mosaicism1-5, yet our knowledge of the causes and consequences of this is limited. Here, using a computational approach, we estimate that 20% of the male population represented in the UK Biobank study (n = 205,011) has detectable LOY. We identify 156 autosomal genetic determinants of LOY, which we replicate in 757,114 men of European and Japanese ancestry. These loci highlight genes that are involved in cell-cycle regulation and cancer susceptibility, as well as somatic drivers of tumour growth and targets of cancer therapy. We demonstrate that genetic susceptibility to LOY is associated with non-haematological effects on health in both men and women, which supports the hypothesis that clonal haematopoiesis is a biomarker of genomic instability in other tissues. Single-cell RNA sequencing identifies dysregulated expression of autosomal genes in leukocytes with LOY and provides insights into why clonal expansion of these cells may occur. Collectively, these data highlight the value of studying clonal mosaicism to uncover fundamental mechanisms that underlie cancer and other ageing-related diseases.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Y/genetics , Genetic Predisposition to Disease/genetics , Genomic Instability/genetics , Leukocytes/pathology , Mosaicism , Adult , Aged , Computational Biology , Databases, Genetic , Female , Genetic Markers/genetics , Humans , Male , Middle Aged , Neoplasms/genetics , United Kingdom
2.
BMC Genomics ; 25(1): 243, 2024 Mar 05.
Article in English | MEDLINE | ID: mdl-38443832

ABSTRACT

BACKGROUND: Mosaic loss of chromosome Y (LOY) in leukocytes is the most prevalent somatic aneuploidy in aging humans. Men with LOY have increased risks of all-cause mortality and the major causes of death, including many forms of cancer. It has been suggested that the association between LOY and disease risk depends on what type of leukocyte is affected with Y loss, with prostate cancer patients showing higher levels of LOY in CD4 + T lymphocytes. In previous studies, Y loss has however been observed at relatively low levels in this cell type. This motivated us to investigate whether specific subsets of CD4 + T lymphocytes are particularly affected by LOY. Publicly available, T lymphocyte enriched, single-cell RNA sequencing datasets from patients with liver, lung or colorectal cancer were used to study how LOY affects different subtypes of T lymphocyte. To validate the observations from the public data, we also generated a single-cell RNA sequencing dataset comprised of 23 PBMC samples and 32 CD4 + T lymphocytes enriched samples. RESULTS: Regulatory T cells had significantly more LOY than any other studied T lymphocytes subtype. Furthermore, LOY in regulatory T cells increased the ratio of regulatory T cells compared with other T lymphocyte subtypes, indicating an effect of Y loss on lymphocyte differentiation. This was supported by developmental trajectory analysis of CD4 + T lymphocytes culminating in the regulatory T cells cluster most heavily affected by LOY. Finally, we identify dysregulation of 465 genes in regulatory T cells with Y loss, many involved in the immunosuppressive functions and development of regulatory T cells. CONCLUSIONS: Here, we show that regulatory T cells are particularly affected by Y loss, resulting in an increased fraction of regulatory T cells and dysregulated immune functions. Considering that regulatory T cells plays a critical role in the process of immunosuppression; this enrichment for regulatory T cells with LOY might contribute to the increased risk for cancer observed among men with Y loss in leukocytes.


Subject(s)
Chromosomes, Human, Y , Neoplasms , Humans , Male , Chromosomes, Human, Y/genetics , T-Lymphocytes, Regulatory , Leukocytes, Mononuclear , Mosaicism
3.
Nat Rev Genet ; 18(2): 128-142, 2017 02.
Article in English | MEDLINE | ID: mdl-27941868

ABSTRACT

Post-zygotic variation refers to genetic changes that arise in the soma of an individual and that are not usually inherited by the next generation. Although there is a paucity of research on such variation, emerging studies show that it is common: individuals are complex mosaics of genetically distinct cells, to such an extent that no two somatic cells are likely to have the exact same genome. Although most types of mutation can be involved in post-zygotic variation, structural genetic variants are likely to leave the largest genomic footprint. Somatic variation has diverse physiological roles and pathological consequences, particularly when acquired variants influence the clonal trajectories of the affected cells. Post-zygotic variation is an important confounder in medical genetic testing and a promising avenue for research: future studies could involve analyses of sorted and single cells from multiple tissue types to fully explore its potential.


Subject(s)
Disease/etiology , Genetic Predisposition to Disease , Genetic Variation/genetics , Genome, Human , Mosaicism , Gene-Environment Interaction , Genomics , Humans , Mutation , Phenotype , Zygote
4.
Cell Mol Life Sci ; 78(8): 4019-4033, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33837451

ABSTRACT

Epidemiological investigations show that mosaic loss of chromosome Y (LOY) in leukocytes is associated with earlier mortality and morbidity from many diseases in men. LOY is the most common acquired mutation and is associated with aberrant clonal expansion of cells, yet it remains unclear whether this mosaicism exerts a direct physiological effect. We studied DNA and RNA from leukocytes in sorted- and single-cells in vivo and in vitro. DNA analyses of sorted cells showed that men diagnosed with Alzheimer's disease was primarily affected with LOY in NK cells whereas prostate cancer patients more frequently displayed LOY in CD4 + T cells and granulocytes. Moreover, bulk and single-cell RNA sequencing in leukocytes allowed scoring of LOY from mRNA data and confirmed considerable variation in the rate of LOY across individuals and cell types. LOY-associated transcriptional effect (LATE) was observed in ~ 500 autosomal genes showing dysregulation in leukocytes with LOY. The fraction of LATE genes within specific cell types was substantially larger than the fraction of LATE genes shared between different subsets of leukocytes, suggesting that LOY might have pleiotropic effects. LATE genes are involved in immune functions but also encode proteins with roles in other diverse biological processes. Our findings highlight a surprisingly broad role for chromosome Y, challenging the view of it as a "genetic wasteland", and support the hypothesis that altered immune function in leukocytes could be a mechanism linking LOY to increased risk for disease.


Subject(s)
Alzheimer Disease/genetics , Chromosomes, Human, Y , Mosaicism , Prostatic Neoplasms/genetics , CD4-Positive T-Lymphocytes/metabolism , Gene Expression Regulation , Humans , Killer Cells, Natural/metabolism , Leukocytes/metabolism , Male
5.
Am J Hum Genet ; 98(6): 1208-1219, 2016 Jun 02.
Article in English | MEDLINE | ID: mdl-27231129

ABSTRACT

Men have a shorter life expectancy compared with women but the underlying factor(s) are not clear. Late-onset, sporadic Alzheimer disease (AD) is a common and lethal neurodegenerative disorder and many germline inherited variants have been found to influence the risk of developing AD. Our previous results show that a fundamentally different genetic variant, i.e., lifetime-acquired loss of chromosome Y (LOY) in blood cells, is associated with all-cause mortality and an increased risk of non-hematological tumors and that LOY could be induced by tobacco smoking. We tested here a hypothesis that men with LOY are more susceptible to AD and show that LOY is associated with AD in three independent studies of different types. In a case-control study, males with AD diagnosis had higher degree of LOY mosaicism (adjusted odds ratio = 2.80, p = 0.0184, AD events = 606). Furthermore, in two prospective studies, men with LOY at blood sampling had greater risk for incident AD diagnosis during follow-up time (hazard ratio [HR] = 6.80, 95% confidence interval [95% CI] = 2.16-21.43, AD events = 140, p = 0.0011). Thus, LOY in blood is associated with risks of both AD and cancer, suggesting a role of LOY in blood cells on disease processes in other tissues, possibly via defective immunosurveillance. As a male-specific risk factor, LOY might explain why males on average live shorter lives than females.


Subject(s)
Alzheimer Disease/genetics , Chromosomes, Human, Y/genetics , Mosaicism , Polymorphism, Single Nucleotide/genetics , Aged , Aged, 80 and over , Alzheimer Disease/blood , Case-Control Studies , Female , Humans , Longitudinal Studies , Male , Middle Aged , Prognosis , Prospective Studies , Risk Factors
6.
Genome Res ; 25(10): 1521-35, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26430163

ABSTRACT

Sporadic breast cancer (SBC) is a common disease without robust means of early risk prediction in the population. We studied 282 females with SBC, focusing on copy number aberrations in cancer-free breast tissue (uninvolved margin, UM) outside the primary tumor (PT). In total, 1162 UMs (1-14 per breast) were studied. Comparative analysis between UM(s), PT(s), and blood/skin from the same patient as a control is the core of the study design. We identified 108 patients with at least one aberrant UM, representing 38.3% of cases. Gains in gene copy number were the principal type of mutations in microscopically normal breast cells, suggesting that oncogenic activation of genes via increased gene copy number is a predominant mechanism for initiation of SBC pathogenesis. The gain of ERBB2, with overexpression of HER2 protein, was the most common aberration in normal cells. Five additional growth factor receptor genes (EGFR, FGFR1, IGF1R, LIFR, and NGFR) also showed recurrent gains, and these were occasionally present in combination with the gain of ERBB2. All the aberrations found in the normal breast cells were previously described in cancer literature, suggesting their causative, driving role in pathogenesis of SBC. We demonstrate that analysis of normal cells from cancer patients leads to identification of signatures that may increase risk of SBC and our results could influence the choice of surgical intervention to remove all predisposing cells. Early detection of copy number gains suggesting a predisposition toward cancer development, long before detectable tumors are formed, is a key to the anticipated shift into a preventive paradigm of personalized medicine for breast cancer.


Subject(s)
Breast Neoplasms/genetics , Breast/anatomy & histology , Mutation , Adult , Aged , Aged, 80 and over , Breast/pathology , Breast Neoplasms/pathology , Cohort Studies , DNA Mutational Analysis , Female , Gene Dosage , Genes, erbB-2 , Genetic Predisposition to Disease , Genotype , Humans , Middle Aged , Receptor, ErbB-2/genetics , Receptors, Growth Factor/genetics , Risk Factors
7.
J Sleep Res ; 27(6): e12708, 2018 12.
Article in English | MEDLINE | ID: mdl-29740901

ABSTRACT

The present study, with an observational period of about 40 years, examined the association between self-reported sleep disturbances (i.e. problems with falling and staying asleep; use of hypnotics) and prostate cancer morbidity and mortality in initially 2322 men (all 50 years old at baseline). Self-reported sleep disturbances and established risk factors (e.g. age, lower urinary tract symptoms, smoking and family history of cancer) were measured at ages 50 and 70 years. Information about prostate cancer diagnosis and deaths as a result of prostate cancer was available from the National Cancer Registry and the Swedish Civil Registry of Morbidity. During the observational period, 263 participants developed prostate cancer (11% of the total cohort); 146 of them died as a result of prostate cancer. There was no association between sleep disturbances and prostate cancer morbidity or mortality (hazard ratio 1.09, 95% confidence interval (CI) 0.79, 1.52, and hazard ratio 1.21, 95% CI 0.77, 1.91, respectively). Similar findings were observed when examining associations between single sleep disturbance parameters and prostate cancer morbidity and mortality. Our study does not provide evidence that reports of sleep disturbances increase the risk of prostate cancer morbidity or mortality in middle to older-aged men. Therefore, assessing subjective sleep problems may not meaningfully help to identify men at risk of developing prostate cancer or dying of this devastating condition.


Subject(s)
Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/mortality , Self Report , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/mortality , Aged , Cohort Studies , Follow-Up Studies , Humans , Longitudinal Studies , Male , Middle Aged , Proportional Hazards Models , Registries , Risk Factors , Surveys and Questionnaires , Sweden/epidemiology , Time Factors
8.
Hum Genet ; 136(5): 657-663, 2017 05.
Article in English | MEDLINE | ID: mdl-28424864

ABSTRACT

Recent discoveries have shown that harboring cells without the Y chromosome in the peripheral blood is associated with increased risk for all-cause mortality and disease such as different forms of cancer, Alzheimer's disease, as well as other conditions in aging men. In the entire world, the life expectancy of men is shorter compared to women, a sex difference that has been known for centuries, but the underlying mechanism(s) are not well understood. As a male-specific genetic risk factor, an increased risk for pathology and mortality associated with mosaic loss of chromosome Y (LOY) in blood cells could help to explain that men on average live shorter lives compared to women. This review primarily focuses on observed associations between LOY in blood and various diseases in aging men. Other topics covered are known risk factors for LOY, methods to detect LOY, and a discussion regarding mechanisms such as immunosurveillance, that could possibly explain how an acquired mutation in blood cells can be associated with disease processes in other organs.


Subject(s)
Aging , Blood Cells/metabolism , Chromosomes, Human, Y/genetics , Alzheimer Disease/genetics , Female , Hematologic Diseases/genetics , Humans , Life Expectancy , Male , Neoplasms/genetics , Risk Factors
11.
Am J Hum Genet ; 90(2): 217-28, 2012 Feb 10.
Article in English | MEDLINE | ID: mdl-22305530

ABSTRACT

Structural variations are among the most frequent interindividual genetic differences in the human genome. The frequency and distribution of de novo somatic structural variants in normal cells is, however, poorly explored. Using age-stratified cohorts of 318 monozygotic (MZ) twins and 296 single-born subjects, we describe age-related accumulation of copy-number variation in the nuclear genomes in vivo and frequency changes for both megabase- and kilobase-range variants. Megabase-range aberrations were found in 3.4% (9 of 264) of subjects ≥60 years old; these subjects included 78 MZ twin pairs and 108 single-born individuals. No such findings were observed in 81 MZ pairs or 180 single-born subjects who were ≤55 years old. Recurrent region- and gene-specific mutations, mostly deletions, were observed. Longitudinal analyses of 43 subjects whose data were collected 7-19 years apart suggest considerable variation in the rate of accumulation of clones carrying structural changes. Furthermore, the longitudinal analysis of individuals with structural aberrations suggests that there is a natural self-removal of aberrant cell clones from peripheral blood. In three healthy subjects, we detected somatic aberrations characteristic of patients with myelodysplastic syndrome. The recurrent rearrangements uncovered here are candidates for common age-related defects in human blood cells. We anticipate that extension of these results will allow determination of the genetic age of different somatic-cell lineages and estimation of possible individual differences between genetic and chronological age. Our work might also help to explain the cause of an age-related reduction in the number of cell clones in the blood; such a reduction is one of the hallmarks of immunosenescence.


Subject(s)
Blood Cells/physiology , DNA Copy Number Variations/genetics , Genome, Human , Adult , Age Factors , Aged , Aged, 80 and over , Child , Cohort Studies , Female , Humans , Individuality , Longitudinal Studies , Middle Aged , Mutation/genetics , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/genetics , Twins, Monozygotic/genetics , Young Adult
12.
Science ; 377(6603): 292-297, 2022 07 15.
Article in English | MEDLINE | ID: mdl-35857592

ABSTRACT

Hematopoietic mosaic loss of Y chromosome (mLOY) is associated with increased risk of mortality and age-related diseases in men, but the causal and mechanistic relationships have yet to be established. Here, we show that male mice reconstituted with bone marrow cells lacking the Y chromosome display increased mortality and age-related profibrotic pathologies including reduced cardiac function. Cardiac macrophages lacking the Y chromosome exhibited polarization toward a more fibrotic phenotype, and treatment with a transforming growth factor ß1-neutralizing antibody ameliorated cardiac dysfunction in mLOY mice. A prospective study revealed that mLOY in blood is associated with an increased risk for cardiovascular disease and heart failure-associated mortality. Together, these results indicate that hematopoietic mLOY causally contributes to fibrosis, cardiac dysfunction, and mortality in men.


Subject(s)
Aging , Chromosome Deletion , Heart Failure , Hematopoietic Stem Cells , Myocardium , Y Chromosome , Aging/genetics , Animals , Antibodies, Neutralizing/pharmacology , Antibodies, Neutralizing/therapeutic use , Fibrosis , Heart Failure/genetics , Heart Failure/therapy , Macrophages , Male , Mice , Mosaicism , Myocardium/pathology , Transforming Growth Factor beta/antagonists & inhibitors , Y Chromosome/genetics
13.
Cell Biosci ; 11(1): 205, 2021 Dec 12.
Article in English | MEDLINE | ID: mdl-34895331

ABSTRACT

BACKGROUND: Mosaic loss of Y chromosome (LOY) is the most common somatic change that occurs in circulating white blood cells of older men. LOY in leukocytes is associated with increased risk for all-cause mortality and a range of common disease such as hematological and non-hematological cancer, Alzheimer's disease, and cardiovascular events. Recent genome-wide association studies identified up to 156 germline variants associated with risk of LOY. The objective of this study was to use these variants to calculate a novel polygenic risk score (PRS) for LOY, and to assess the predictive performance of this score in a large independent population of older men. RESULTS: We calculated a PRS for LOY in 5131 men aged 70 years and older. Levels of LOY were estimated using microarrays and validated by whole genome sequencing. After adjusting for covariates, the PRS was a significant predictor of LOY (odds ratio [OR] = 1.74 per standard deviation of the PRS, 95% confidence intervals [CI] 1.62-1.86, p < 0.001). Men in the highest quintile of the PRS distribution had > fivefold higher risk of LOY than the lowest (OR = 5.05, 95% CI 4.05-6.32, p < 0.001). Adding the PRS to a LOY prediction model comprised of age, smoking and alcohol consumption significantly improved prediction (AUC = 0.628 [CI 0.61-0.64] to 0.695 [CI 0.67-0.71], p < 0.001). CONCLUSIONS: Our results suggest that a PRS for LOY could become a useful tool for risk prediction and targeted intervention for common disease in men.

14.
Sci Rep ; 11(1): 15160, 2021 07 26.
Article in English | MEDLINE | ID: mdl-34312421

ABSTRACT

Mosaic loss of chromosome Y (LOY) in immune cells is a male-specific mutation associated with increased risk for morbidity and mortality. The CD99 gene, positioned in the pseudoautosomal regions of chromosomes X and Y, encodes a cell surface protein essential for several key properties of leukocytes and immune system functions. Here we used CITE-seq for simultaneous quantification of CD99 derived mRNA and cell surface CD99 protein abundance in relation to LOY in single cells. The abundance of CD99 molecules was lower on the surfaces of LOY cells compared with cells without this aneuploidy in all six types of leukocytes studied, while the abundance of CD proteins encoded by genes located on autosomal chromosomes were independent from LOY. These results connect LOY in single cells with immune related cellular properties at the protein level, providing mechanistic insight regarding disease vulnerability in men affected with mosaic chromosome Y loss in blood leukocytes.


Subject(s)
12E7 Antigen/blood , Chromosomes, Human, Y/genetics , Leukocytes/immunology , Mosaicism , 12E7 Antigen/deficiency , 12E7 Antigen/genetics , Aged , Aged, 80 and over , Aging/blood , Aging/genetics , Aging/immunology , Alzheimer Disease/blood , Alzheimer Disease/genetics , Alzheimer Disease/immunology , Chromosomes, Human, Y/immunology , Chromosomes, Human, Y/metabolism , Humans , Leukocytes/metabolism , Male , Mutation , RNA, Messenger/blood , RNA, Messenger/genetics , Single-Cell Analysis
15.
Am J Med Genet A ; 152A(10): 2595-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20734341

ABSTRACT

Somatic genetic variation in health and disease is poorly explored. Monozygotic (MZ) twins are a suitable model for studies of somatic mosaicism since genetic differences in twins derived from the same zygote represent an irrefutable example of somatic variation. We report the analysis of a pair of generally healthy female MZ twins, discordant for somatic mosaicism for aneuploidy of chromosomes X and Y. Both twins are heterozygous carriers of sickle cell disease mutation. Genotyping of blood DNA from both twins using Illumina Human 610 SNP array revealed a copy number imbalance for chromosome X in a proportion of cells in one twin. Fluorescent in situ hybridization (FISH) analysis confirmed monosomy X (45,X) in 7% of proband nucleated blood cells. Unexpectedly, FISH analysis of cells from the other twin revealed 45,X and 46,XY lineages, both present in 1% of cells. The mechanism behind formation of these aneuploidies suggests several aberrant chromosome segregation events in meiosis and mitoses following conception. Our report contributes to the delineation of the frequency of somatic structural genomic variation in normal MZ twins. These results also illustrate the plasticity of the human genome for tolerating large copy number changes in healthy subjects and show the sensitivity of the Illumina platform for detection of aberrations that are present in a minority of the studied cells.


Subject(s)
Anemia, Sickle Cell/genetics , Aneuploidy , Chromosomes, Human, X/genetics , Chromosomes, Human, Y/genetics , Turner Syndrome/genetics , Twins, Monozygotic/genetics , Chromosomes, Human, Pair 18/genetics , Female , Genetic Variation , Genotype , Heterozygote , Humans , Male , Middle Aged
16.
Eur J Hum Genet ; 28(3): 349-357, 2020 03.
Article in English | MEDLINE | ID: mdl-31654039

ABSTRACT

Mosaic loss of chromosome Y (LOY) is the most common somatic genetic aberration and is associated with increased risk for all-cause mortality, various forms of cancer and Alzheimer's disease, as well as other common human diseases. By tracking LOY frequencies in subjects from which blood samples have been serially collected up to five times during up to 22 years, we observed a pronounced intra-individual variation of changes in the frequency of LOY within individual men over time. We observed that in some individuals the frequency of LOY in blood clearly progressed over time and that in other men, the frequency was constant or showed other types of longitudinal development. The predominant method used for estimating LOY is calculation of the median Log R Ratio of probes located in the male specific part of chromosome Y (mLRRY) from intensity data generated by SNP-arrays, which is difficult to interpret due to its logarithmic and inversed scale. We present here a formula to transform mLRRY-values to percentage of LOY that is a more comprehensible unit. The formula was derived using measurements of LOY from matched samples analysed using SNP-array, whole genome sequencing and a new AMELX/AMELY-based assay for droplet digital PCR. The methods described could be applied for analyses of the vast amount of SNP-array data already generated in the scientific community, allowing further discoveries of LOY associated diseases and outcomes.


Subject(s)
Aging/genetics , Chromosome Deletion , Chromosomes, Human, Y/genetics , Mosaicism , Polymorphism, Genetic , Aging/blood , Blood Cells/metabolism , Humans , Male
17.
Leukemia ; 33(5): 1184-1194, 2019 05.
Article in English | MEDLINE | ID: mdl-30573780

ABSTRACT

Acquired uniparental disomy (aUPD, also known as copy-neutral loss of heterozygosity) is a common feature of cancer cells and characterized by extended tracts of somatically-acquired homozygosity without any concurrent loss or gain of genetic material. The presumed genetic targets of many regions of aUPD remain unknown. Here we describe the association of chromosome 22 aUPD with mutations that delete the C-terminus of PRR14L in patients with chronic myelomonocytic leukemia (CMML), related myeloid neoplasms and age-related clonal hematopoiesis (ARCH). Myeloid panel analysis identified a median of three additional mutated genes (range 1-6) in cases with a myeloid neoplasm (n = 8), but no additional mutations in cases with ARCH (n = 2) suggesting that mutated PRR14L alone may be sufficient to drive clonality. PRR14L has very limited homology to other proteins and its function is unknown. ShRNA knockdown of PRR14L in human CD34+ cells followed by in vitro growth and differentiation assays showed an increase in monocytes and decrease in neutrophils, consistent with a CMML-like phenotype. RNA-Seq and cellular localization studies suggest a role for PRR14L in cell division. PRR14L is thus a novel, biallelically mutated gene and potential founding abnormality in myeloid neoplasms.


Subject(s)
Chromosomal Proteins, Non-Histone/genetics , Chromosomes, Human, Pair 22 , Hematopoiesis/genetics , Mutation , Myeloproliferative Disorders/genetics , Uniparental Disomy , Cell Differentiation/genetics , Female , Fluorescent Antibody Technique , Gene Expression Regulation, Leukemic , Gene Knockdown Techniques , Gene Knockout Techniques , Humans , Male , Myeloproliferative Disorders/diagnosis , Phenotype , Polymorphism, Single Nucleotide , Exome Sequencing
19.
Endocr Relat Cancer ; 24(8): 427-443, 2017 08.
Article in English | MEDLINE | ID: mdl-28634180

ABSTRACT

The genetics behind predisposition to small intestinal neuroendocrine tumors (SI-NETs) is largely unknown, but there is growing awareness of a familial form of the disease. We aimed to identify germline mutations involved in the carcinogenesis of SI-NETs. The strategy included next-generation sequencing of exome- and/or whole-genome of blood DNA, and in selected cases, tumor DNA, from 24 patients from 15 families with the history of SI-NETs. We identified seven candidate mutations in six genes that were further studied using 215 sporadic SI-NET patients. The result was compared with the frequency of the candidate mutations in three control cohorts with a total of 35,688 subjects. A heterozygous variant causing an amino acid substitution p.(Gly396Asp) in the MutY DNA glycosylase gene (MUTYH) was significantly enriched in SI-NET patients (minor allele frequencies 0.013 and 0.003 for patients and controls respectively) and resulted in odds ratio of 5.09 (95% confidence interval 1.56-14.74; P value = 0.0038). We also found a statistically significant difference in age at diagnosis between familial and sporadic SI-NETs. MUTYH is involved in the protection of DNA from mutations caused by oxidative stress. The inactivation of this gene leads to specific increase of G:C- > T:A transversions in DNA sequence and has been shown to cause various cancers in humans and experimental animals. Our results suggest that p.(Gly396Asp) in MUTYH, and potentially other mutations in additional members of the same DNA excision-repair pathway (such as the OGG1 gene) might be involved in driving the tumorigenesis leading to familial and sporadic SI-NETs.


Subject(s)
DNA Glycosylases/genetics , Intestinal Neoplasms/genetics , Neuroendocrine Tumors/genetics , Adult , Aged , DNA Glycosylases/metabolism , Female , Germ-Line Mutation , Humans , Intestinal Neoplasms/metabolism , Male , Middle Aged , Neuroendocrine Tumors/metabolism
20.
Eur J Hum Genet ; 29(9): 1323-1324, 2021 09.
Article in English | MEDLINE | ID: mdl-33462398
SELECTION OF CITATIONS
SEARCH DETAIL